Results 121 to 130 of about 3,939,990 (297)

Amplification of Gene-Regulating Regions with Single-Sided Specificity.

open access: yes, 1997
FRom molecular cloning to Genetic ...
Luo MZ, CELLA, RINO
core  

Cloning

open access: yes, 2016
Educação Superior::Ciências Biológicas::BioquímicaPresents different types of cloning (molecular, cellular or from the organisms), how the cloning process occurs and the enzyme responsible for the DNA fragmentationBasic cellular ...
LeanersTV
core   +1 more source

Cloning and molecular characterization of an estrogen-dependent human oviduct-specific glycoprotein.

open access: yes, 1997
Cloning and molecular characterization of an estrogen-dependent human oviduct-specific ...
Edward Belisario. Arias (7988693)
core   +2 more sources

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Characterization of the cpt1b Gene in Response to a Tributyrin-Supplemented Diet: Cloning, Tissue-Specific Expression, and Intestinal Metabolic Function in Mandarin Fish (Siniperca chuatsi)

open access: yesCurrent Issues in Molecular Biology
Tributyrin (TB), as a novel feed additive, holds broad market prospects and is crucial for promoting fish growth and maintaining intestinal health.
Er-Xue Xu   +6 more
doaj   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Cloning Research Forum at the National Academy of Sciences (2001 August 7)

open access: yes, 2001
National Academy of Sciences forum on cloning research filmed in five parts on August 7, 2001. Segments focus on: human cloning research, human reproductive cloning, human cloning public policy issues, cloning for stem cells, and animal and human ...
Producer: National Cable Satellite Corporation. C-SPAN
core  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors

open access: yesBiomolecules
For the first time, two poly-histidine-poly-glycine peptides (pHpG-H5 and pHpG-H7) were identified as promising candidates for matrix metalloproteinase inhibitors. cDNAs encoding pHpG-H5 and pHpG-H7 peptides were isolated from the Atheris squamigera cDNA
He Wang   +8 more
doaj   +1 more source

Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma

open access: yesMolecular Oncology, EarlyView.
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy